Healthy volunteers needed to test new Drug's safety
NCT ID NCT07566130
First seen May 06, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This early-stage study is testing a new drug called nacresertib in 96 healthy adults to see if it is safe and how the body processes it. Participants will take either a single dose or multiple doses of the drug. The goal is to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 274374
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.